Perspectives
Getting naloxone in the hands of high-risk members
Pharmacists targeted high-risk members at point of sale
February 1, 2019When pharmacists reached out to members picking up an opioid prescription to give them information about naloxone, targeting them at the pharmacy proved impactful.
We knew that members with opioid prescriptions weren’t getting enough information about opioid risks. For this study, Prime used its controlled substance (CS) scoring system to identify members at high risk for opioid overdose and death. When targeted members with high CS scores picked up an opioid prescription, a Walgreens pharmacist provided an Opioid Safety Guide. Members who received an Opioid Safety Guide were four times more likely to get a prescription of naloxone within 6-months, than did members who had not received the Safety Guide.
Related news
Perspectives
April 17, 2024
AMCP 2024: Behind the research with YuQian Liu
Ahead of her session with Andy Killpack, Liu — senior director of specialty clinical solutions at Prime/MRx — shares current care management strategies for cell and gene therapy and the future of this exciting frontier
Perspectives
April 16, 2024
AMCP 2024: Behind the research with Jacob LaRue and Timothy O’Shea
Ahead of their session, Jacob and Timothy share how Prime/MRx is working alongside providers like Horizon Blue Cross Blue Shield of New Jersey to manage drug waste and rein in spend for specialty drugs without therapeutic impact to patients
Perspectives
April 15, 2024
Oncology Insights: Cancer treatment is personal
Precision medicine, or personalized medicine, uses genes or proteins to diagnose or treat disease. This medical care design has significantly impacted oncology and grew out of a need to improve and individualize patient treatments